IDiyas

For the Inventor, By the Inventor

Lindlar, Germany

Bernard Schmidt

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 9.1

ph-index = 6

Forward Citations = 96(Granted Patents)


Location History:

  • Lindlar, DE (1995 - 2003)
  • Lindlard, DE (2003)

Company Filing History:

goldMedal17 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1995-2003

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 6630494 - Phenyl-substituted 1,4-dihydropyridines (2003-10-07),
2. 6589949 - 3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases (2003-07-08),
3. 6239155 - Phenyl-substituted 1,4-dihydropyridines (2001-05-29),
4. 6174897 - Bis-(quinolyl)-diamines (2001-01-16),
5. 6066655 - 4-phenyl-3-substituted 1,4-dihydropyridine esters (2000-05-23),
6. 6001857 - Heterocyclyl substituted dihydropyridines (1999-12-14),
7. 5874438 - 2,2'-bridged bis-2,4-diaminoquinazolines (1999-02-23),
8. 5866562 - Ring-bridged bis-quinolines (1999-02-02),
9. 5760230 - 4, 4'-bridged bis-2, 4-diaminoquinazolines (1998-06-02),
10. 5756517 - Use of bisquinoline compounds in the treatment of cerebral disorders (1998-05-26),
11. 5739127 - 2,4'-bridged bis-2,4-diaminoquinazolines (1998-04-14),
12. 5731333 - 4-phenyl-3-substituted 1,4-dihydropyridine esters (1998-03-24),
13. 5665740 - Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, (1997-09-09),
14. 5658934 - Aryl-substituted alkoxycarbonyl-1,4-dihydropyridine-5-carboxylic acid (1997-08-19),
15. 5547965 - Use of substituted amines for the treatment of brain function disorders (1996-08-20),

Title: The Innovative Contributions of Bernard Schmidt

Introduction

Bernard Schmidt is a notable inventor based in Lindlar, Germany. He has made significant contributions to the field of medicinal chemistry, holding a total of 17 patents. His work primarily focuses on developing novel compounds that can be utilized in the treatment of various central nervous system diseases.

Latest Patents

Among his latest patents, Schmidt has developed phenyl-substituted 1,4-dihydropyridines. These compounds are prepared by reacting halogenophenyl-aldehydes with β-ketoesters, and they can serve as active ingredients in medicaments, particularly in cerebrally active compositions. Another significant patent involves 3-oxo-2,1-benzisoxazol-1(3H)-carboxamides, which are designed for the treatment of CNS diseases. This invention includes a range of novel compounds that can be used in the production of medicaments aimed at preventing or treating cognitive disorders, such as Alzheimer's disease and other forms of dementia.

Career Highlights

Throughout his career, Bernard Schmidt has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Animal Health GmbH. His experience in these organizations has allowed him to contribute to the development of innovative medicinal products.

Collaborations

Schmidt has collaborated with several notable professionals in his field, including Rudolf Schohe-Loop and Wolfgang Hartwig. These partnerships have further enhanced his research and development efforts.

Conclusion

Bernard Schmidt's innovative work in medicinal chemistry has led to the development of important compounds for treating CNS diseases. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…